SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 270 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $338,000 | -83.1% | 4,679 | -67.1% | 0.11% | -83.5% |
| Q3 2019 | $1,998,000 | -24.6% | 14,240 | -1.6% | 0.67% | -27.4% |
| Q2 2019 | $2,649,000 | +9.0% | 14,470 | -0.3% | 0.92% | +10.5% |
| Q1 2019 | $2,430,000 | +74.1% | 14,520 | -0.4% | 0.83% | +64.4% |
| Q4 2018 | $1,396,000 | -12.8% | 14,575 | +28.6% | 0.50% | +3.7% |
| Q3 2018 | $1,600,000 | – | 11,330 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |